FDA Approved: PLERIXAFOR — Supplemental Application (Eugia US LLC)

View source ↗

Summary

FDA approved a supplemental application for a generic version of Plerixafor submitted by Eugia US LLC.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Multiple Myeloma
• Non-hodgkin Lymphoma

Drugs mentioned

• Plerixafor (Plerixafor)

Snippet

SUPPL AP for PLERIXAFOR (PLERIXAFOR)